{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:57:20Z","timestamp":1792785440852,"version":"4.5.0"},"reference-count":9,"publisher":"Informa UK Limited","issue":"16","funder":[{"name":"Merck Serono, an affiliate of Merck KGaA, Darmstadt"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.1080\/14656566.2020.1792885","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T16:13:00Z","timestamp":1594656780000},"page":"1965-1969","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinion"],"prefix":"10.1080","volume":"21","author":[{"given":"Sven G.","family":"Meuth","sequence":"first","affiliation":[{"name":"Abteilung f\u00fcr Neurologie, Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Bayas","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Neurologie und Klinische Neurophysiologie, Universit\u00e4tsklinikum Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Kallmann","sequence":"additional","affiliation":[{"name":"Multiple Sklerose Zentrum Bamberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kleinschnitz","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Neurologie, Universit\u00e4tsklinikum Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Linker","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Neurologie, Universit\u00e4tsklinikum Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rieckmann","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Neurologie, Medical Park Loipl, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"M\u00e4urer","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Neurologie, Juliusspital W\u00fcrzburg Klinikum W\u00fcrzburg Mitte gGmbH, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902533"},{"key":"cit0002","volume-title":"Increase of na\u00efve B cells, M2 macrophages and reduction of memory B\/T cells during immune repopulation at 96 weeks in CLARITY assessed by immune cell deconvolution","author":"Giovannoni G"},{"key":"cit0003","unstructured":"EMA summary of product charateristics: Mavenclad\u00ae (cladribine tablets). 2020 Jan."},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517727603"},{"key":"cit0005","doi-asserted-by":"crossref","volume-title":"Long-term disease stability assessed by the expanded disability status scale in patients treated with cladribine tablets in the CLARITY and CLARITY extension studies","author":"Giovannoni G","DOI":"10.1016\/j.jns.2019.10.291"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1177\/1756286420922685"},{"key":"cit0007","volume-title":"Poster P112 presented at the 91th Congress of the Deutsche Gesellschaft f\u00fcr Neurologie (DGN)","author":"Penner IK","year":"2018"},{"key":"cit0008","unstructured":"Krankheitsbezogenes Kompetenznetz Multiple Sklerose (KKNMS) Qualit\u00e4tshandbuch MS\/NMOSD. 2020 Jan."},{"key":"cit0009","unstructured":"EMA summary of product charateristics: Lemtrada\u00ae (alemtuzumab). 2020 Jan."}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2020.1792885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T05:31:48Z","timestamp":1620451908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2020.1792885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":9,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2020,11,1]]}},"alternative-id":["10.1080\/14656566.2020.1792885"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2020.1792885","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}